drug
as of 2026-07-01Flupentixol
Flupentixole
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Hannover Medical School
4 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
SchizophreniaDepressionPsychosomatic DisordersCentral Nervous System DiseasesSchizophrenia Spectrum and Other Psychotic DisordersSchizophreniaOlanzapineAnxiety DisordersSchizophrenia; PsychosisDepressionClinical TherapyPsychotic DisordersSchizoaffective DisordersPsychophysiologic DisordersDementiaCentral Nervous System Diseases
Trials
4
Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients
NCT04898270Phase 4Completed
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567Phase 3Terminated
KOLs & investigators
4
Stefan Leucht, ProfessorKOL score 87
Helge Frieling, Prof., MDKOL score 5
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication
indication
indication
KOL
Stefan Leucht, Professor
personKOL score 87
Helge Frieling, Prof., MD
personKOL score 5
Chia-Jui Tsai, M.D.
personKOL score —
Markus Dold, MD
personKOL score —